![usa today tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity An example of patient Title:[Sensolin] Color:Navy Blue](https://mma.prnewswire.com/media/2488923/Eli_Lilly_and_Company_Zepbound_Vials.jpg?p=twitter)
![usa today tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity An example of patient Title:[Sensolin] Color:Navy Blue](https://www.arthritisresearch.ca/wp-content/uploads/GLPs_1-3-scaled.png)
![usa today tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity An example of patient Title:[Sensolin] Color:Navy Blue](https://img.bgo.one/news-image/ai_generated/2026-04/ce054c3082f38752_1777394363_inline_1.jpg)
![usa today tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity An example of patient Title:[Sensolin] Color:Navy Blue](https://assets.efusercontent.com/2978/offers/3566/thumb/3566-thumbnail.jpg)
Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
usa today tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity An example of patient Title:[Sensolin] Color:Navy Blue
An example of patient instructions for microdosing tirzepatide in... | Download Scientific Diagram
Evaluation of the pharmacokinetics and safety of AMG 986 tablet and capsule formulations in healthy adult subjects: a phase I, open-label, randomized study
Title:[Sensolin]
Color:Navy Blue
According to reported trial data, adults taking the 12 mg dose lost an average of 70.3 pounds, equal to about 28.3% of body weight, over 80 weeks
